Abstract:Background: Lymphopenia is defined as a decrease below normal value (often 1.0 x 109 cells/L) of blood circulating lymphocyte count. In the general population, lymphopenia is associated with an increased risk of hospitalisation secondary to infection, independent of traditional clinical risk factors. In hospital, lymphopenia is associated with increased risk of healthcare-associated infection and mortality. By summarising lymphopenia's prevalence and impact on clinical outcomes, we can identify an at-risk population and inform future studies of immune dysfunction following severe illness. Methods: Peer-reviewed search strategy was performed on three databases. Primary objective was to summarise the pooled prevalence of lymphopenia. Primary outcome was infection including pre-existing lymphopenia as a risk factor for admission with infection and as an in-hospital risk factor for healthcare-associated infection. Secondary outcomes were length of stay and mortality. Mortality data extracted included in-hospital, 28/30-day ('early'), and 90-day/1-year ('late') mortality. Meta-analysis was carried out using random-effects models for each outcome measure. Heterogeneity was assessed using I2 statistic. Joanna Briggs Institute checklist for cohort studies was used to assess risk of bias. The protocol was published on PROSPERO. Results: Fifteen observational studies were included. The pooled prevalence of lymphopenia in all-cause hospitalisations was 38% (CI 0.34-0.42, I2= 97%, p< 0.01). Lymphopenia was not associated with an infection diagnosis at hospital admission and healthcare associated infection (RR 1.03; 95% CI 0.26-3.99, p=0.97, I2 = 55% and RR 1.31; 95% CI 0.78-2.20, p=0.31, I2=97%, respectively), but was associated with septic shock (RR 2.72; 95% CI 1.02-7.21, p=0.04, I2 =98%). Lymphopenia was associated with higher in-hospital mortality and higher 'early' mortality rates (RR 2.44; 95% CI 1.71-3.47, p < 0.00001, I2 = 89% and RR 2.05; 95% CI 1.64-2.56, p < 0.00001, I2 = 29%, respectively). Lymphopenia was associated with higher 'late' mortality (RR 1.59; 1.33-1.90, p < 0.00001, I2 = 0%). Conclusions: This meta-analysis demonstrates the high prevalence of lymphopenia across all-cause hospitalisations and associated increased risk of septic shock, early and late mortality. Lymphopenia is a readily available marker that may identify immune dysfunctional patients. Greater understanding of immune trajectories following survival may provide insights into longer-term poor clinical outcomes.

Lymphopenia Caused by Virus Infections and the Mechanisms Beyond

The Putative Mechanism of Lymphopenia in COVID-19 Patients

Possible Mechanisms of Lymphopenia in Severe Tuberculosis

Lymphopenia predicted illness severity and recovery in patients with COVID-19: A single-center, retrospective study

Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis

Lymphopenia in sepsis: a narrative review

Lymphopenia As an Indicator of Severe Pandemic H1N1 Influenza A Infection

SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147

Dynamic changes of lymphocyte counts in adult patients with severe pandemic H1N1 influenza A.

Effects of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection on Peripheral Blood Lymphocytes and Their Subsets

Restoration of Leukomonocyte Counts is Associated with Viral Clearance in COVID-19 Hospitalized Patients

Prolonged lymphopenia and prognoses among inpatients with different respiratory virus infections: A retrospective cohort study

Long non-coding RNAs and immune cells: Unveiling the role in viral infections

Carcinogenic mechanisms of virus-associated lymphoma

SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs

COVID-19: immunopathogenesis and Immunotherapeutics

Interleukin-10-Mediated Lymphopenia Caused by Acute Infection with Foot-and-Mouth Disease Virus in Mice

Pooled prevalence of lymphopenia in all-cause hospitalisations and association with infection: a systematic review and meta-analysis

Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story

Lymphocyte Integrins Mediate Entry and Dysregulation of T Cells by SARS-CoV-2

Human Infections with Neglected Vector-Borne Pathogens in China: A Systematic Review